Product Images Clonidine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Clonidine NDC 75907-025 by Dr. Reddy's Labratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text provides information about the Clonidine Transdermal System, which delivers 0.1 mg per day for one week. It warns against undergoing an MRI with the patch on to avoid burns. The system contains 3.09 mg of Clonidine along with various inactive ingredients. The product is intended for use as prescribed (Rx Only) and manufactured by Dr. Reddy's Laboratories.*
This text provides information about an adhesive cover that does not contain active medication and should be applied over a patch, if necessary. It also mentions that suggestions for usage can be found in the patient information sheet.*
This is a description of a Clonidine Transdermal System USP for delivering 0.2 mg per day over the course of one week. It contains specific instructions such as removing the patch before an MRI procedure to avoid burns. The package includes 4 systems and 4 adhesive covers. The transdermal system contains 6.19 mg of clonidine and lists inactive ingredients. It is for transdermal use only, and the usual dosage information can be found in the package insert. The medication should be kept out of reach of children and stored at 20° to 25°C. The product is distributed by Dr. Reddy's Laboratories in Princeton.*
This is a description of Clonidine Transdermal System USP delivering 0.1 mg/day for one week. Each system contains 3.09 mg of clonidine. It includes instructions such as removing the patch before an MRI, storing at 20-25°C, and keeping out of reach of children. The system consists of 4 systems and 4 adhesive covers with programmed delivery. Inactive ingredients include aluminum, silicon dioxide, and mineral oil. The text specifies it is for transdermal use only with dosage details provided in the package insert.*
This text provides useful information about Clonidine Transdermal System USP, including the dosage of 0.3 mg/day, instructions for use, and precautions such as avoiding MRI procedures with the patch on to prevent burns. It also lists the inactive ingredients and storage instructions. The product is distributed by Dr. Reddy's Laboratories and contains 4 systems and 4 adhesive covers.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.